House Committee to Question FDA on Future of Avastin MBC Indication

House Energy and Commerce Committee Chair Fred Upton (R-Mich.) is expected to question senior FDA officials this week about the agency’s upcoming decision on whether to keep Avastin’s metastatic breast cancer (MBC) indication.
Drug Industry Daily